Biodesix, INC.
Fully integrated molecular diagnostic company.
Based in CO
AI Overview
With $1.0M in lobbying spend across 34 quarterly filings, Biodesix, INC is a significant lobbying presence. Their lobbying covers 3 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $120K |
| 2019 | $120K |
| 2020 | $120K |
| 2021 | $150K |
| 2022 | $120K |
| 2023 | $120K |
| 2024 | $150K |
| 2025 | $120K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Biodesix, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, MED, Health Issues
Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014.
Implementation of changes to Medicare payments for clinical laboratory tests.
Medicare treatment of outpatient reimb
FDA regulation of laboratory developed tests.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.